{"id":62327,"date":"2025-12-09T16:05:52","date_gmt":"2025-12-09T15:05:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/"},"modified":"2025-12-09T16:05:52","modified_gmt":"2025-12-09T15:05:52","slug":"alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/","title":{"rendered":"ALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program"},"content":{"rendered":"
\n

\nOne of Only Five Organizations Selected Nationwide, ALAS to Pilot New Model with Stanford University School of Medicine Centered on “Cultura Cura”<\/b>\n<\/p>\n

HALF MOON BAY, Calif.–(BUSINESS WIRE)–#alascolibriwellnessprogram<\/a>–Out of more than 300 applicants, Ayudando Latinos a So\u00f1ar<\/a> (ALAS) was selected as one of only five organizations in the U.S. to receive a prestigious $200,000 national research grant from the Robert Wood Johnson Foundation<\/a> to advance the Colibr\u00ed Child Wellness Program<\/a> (CCWP). CCWP is a community-driven initiative developed in partnership with Stanford University School of Medicine. ALAS will lead a pilot through the Early Childhood Systems Alignment Initiative (ECSA) to improve access to integrated, culturally responsive early childhood clinical and developmental care for Latino and farmworker families on California\u2019s San Mateo County Coastside.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nThis collaboration is led in partnership with the Developmental-Behavioral Pediatrics team at Stanford University School of Medicine. The initiative builds on more than a decade of trauma-informed, culturally grounded work and seeks to redesign fragmented early childhood systems by centering trusted community infrastructure \u2013 local parents, farmworkers, and educators who are trained in research design and meet biweekly to co-develop and approve all research activities. Guided by the principle of cultura cura<\/i> (\u201cculture cures\u201d), the program directly addresses systemic barriers in early childhood care, including language inaccessibility, fragmented referrals, disinvestment in clinical infrastructure, and institutional distrust.\n<\/p>\n

\n“This national recognition affirms what our families and community have always known: when care is rooted in culture, trust, and belonging, children thrive,\u201d said Dr. Belinda Hernandez Arriaga, EdD, LCSW, Founder and Chief Executive Officer of ALAS. \u201cLatino and farmworker families have faced systemic barriers to early developmental care for far too long. Through this partnership, we are building a model that meets families where they are\u2014from the clinic to the community to the farm fields\u2014so every child has the opportunity to flourish.\u201d\n<\/p>\n

\n\u201cThis work represents a new model for how early childhood systems can be built\u2014with families, apart from them,\u201d said Dr. Annie Berens, MD, Director of Research at ALAS. \u201cOur partnership with Stanford integrates clinical care, developmental screening, and family support in ways that honor culture, language, and lived experience.\u201d\n<\/p>\n

\n\u201cIt is not enough to simply offer life-changing programs for our families,\u201d said Antonio L\u00f3pez, Associate Director of Research & Advocacy at ALAS. \u201cThis moment calls for research-driven interventions that help us to better understand the crises our families face, and how to best assist them.\u201d\n<\/p>\n

\nFrom Pilot to Practice<\/b>\n<\/p>\n

\nThe Colibr\u00ed Child Wellness Program expands an earlier ALAS\u2013Stanford pilot (PRIMES) into a full-spectrum clinical model that delivers bilingual developmental screenings, speech and occupational therapy, behavioral care, Early Start referrals, and parenting support both on-site and via the ALAS Equity Express Bus, which reaches geographically and linguistically isolated farmworker families. The study will enroll families participating in the intervention and families receiving standard care through clinical pipelines and regional center referrals. Mixed-methods research will assess feasibility, acceptability, and early indicators of systems-level impact, including piloting the Measure of Immigration-related Stress, Trauma, and Strengths in Children (MIST-C).\n<\/p>\n

\nSustained community support ensures families can continue receiving care without cost barriers. To help expand access and meet growing needs, donate or learn more at www.alasdreams.com<\/a>.\n<\/p>\n

\nAbout Systems for Action<\/b>\n<\/p>\n

\nSystems for Action<\/a> is a national program of the Robert Wood Johnson Foundation that aims to discover and apply new evidence about ways of aligning the delivery and financing systems that support a Culture of Health.\n<\/p>\n

\nAbout Robert Wood Johnson Foundation (RWJF)<\/b>\n<\/p>\n

\nR<\/a>WJF<\/a> is a leading national philanthropy dedicated to taking bold leaps to transform health in our lifetime. To get there, we must work to dismantle structural racism and other barriers to health. Through funding, convening, advocacy, and evidence-building, we work side-by-side with communities, practitioners, and institutions to get to health equity faster and pave the way together to a future where health is no longer a privilege, but a right.\n<\/p>\n

\nThe views expressed here do not necessarily reflect the views of the Robert Wood Johnson Foundation.\n<\/p>\n

\nAbout Ayudando Latinos a So\u00f1ar (ALAS)<\/b>\n<\/p>\n

\nAyudando Latinos a So\u00f1ar (ALAS) is a Latino-led, community-based organization in Half Moon Bay dedicated to advancing the health, cultural leadership, and resilience of Latino and farmworker families. ALAS provides bilingual mental health services, early childhood and parent education programs, cultural arts, community organizing, and mobile outreach through the ALAS Equity Express Bus, which brings care directly to families in isolated agricultural regions. Founded in 2011, ALAS is rooted in the belief that cultura cura<\/i> (\u201cculture cures\u201d) and that community wellness grows from trust, dignity, and belonging. For more information, please visit: www.alasdreams.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
\n<\/b>
Victoria Sanchez De Alba
\n
De Alba Communications, for ALAS
\n
650-270-7810
\n
victoria@dealba.net<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

One of Only Five Organizations Selected Nationwide, ALAS to Pilot New Model with Stanford University School of Medicine Centered on “Cultura Cura” HALF MOON BAY, Calif.–(BUSINESS WIRE)–#alascolibriwellnessprogram–Out of more than 300 applicants, Ayudando Latinos a So\u00f1ar (ALAS) was selected as one of only five organizations in the U.S. to receive a prestigious $200,000 national research … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62327","6":"format-standard","7":"category-industry"},"yoast_head":"\nALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"One of Only Five Organizations Selected Nationwide, ALAS to Pilot New Model with Stanford University School of Medicine Centered on “Cultura Cura” HALF MOON BAY, Calif.–(BUSINESS WIRE)–#alascolibriwellnessprogram–Out of more than 300 applicants, Ayudando Latinos a So\u00f1ar (ALAS) was selected as one of only five organizations in the U.S. to receive a prestigious $200,000 national research ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-09T15:05:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251204772333\/en\/2660784\/22\/ALAS_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program\",\"datePublished\":\"2025-12-09T15:05:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/\"},\"wordCount\":797,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251204772333\\\/en\\\/2660784\\\/22\\\/ALAS_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/\",\"name\":\"ALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251204772333\\\/en\\\/2660784\\\/22\\\/ALAS_logo.jpg\",\"datePublished\":\"2025-12-09T15:05:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251204772333\\\/en\\\/2660784\\\/22\\\/ALAS_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251204772333\\\/en\\\/2660784\\\/22\\\/ALAS_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/","og_locale":"en_US","og_type":"article","og_title":"ALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program - Pharma Trend","og_description":"One of Only Five Organizations Selected Nationwide, ALAS to Pilot New Model with Stanford University School of Medicine Centered on “Cultura Cura” HALF MOON BAY, Calif.–(BUSINESS WIRE)–#alascolibriwellnessprogram–Out of more than 300 applicants, Ayudando Latinos a So\u00f1ar (ALAS) was selected as one of only five organizations in the U.S. to receive a prestigious $200,000 national research ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-09T15:05:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251204772333\/en\/2660784\/22\/ALAS_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program","datePublished":"2025-12-09T15:05:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/"},"wordCount":797,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251204772333\/en\/2660784\/22\/ALAS_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/","url":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/","name":"ALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251204772333\/en\/2660784\/22\/ALAS_logo.jpg","datePublished":"2025-12-09T15:05:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251204772333\/en\/2660784\/22\/ALAS_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251204772333\/en\/2660784\/22\/ALAS_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/alas-receives-prestigious-national-research-grant-to-advance-the-colibri-child-wellness-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ALAS Receives Prestigious National Research Grant to Advance the Colibr\u00ed Child Wellness Program"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62327"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62327\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62327"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62327"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}